跳至主要内容
临床试验/NCT04972604
NCT04972604已完成不适用

CureDuchenne Link®: A Resource to Support Research Studies in Duchenne and Becker Muscular Dystrophy (DMD/BMD)

CureDuchenne10 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2021年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
240
试验地点
10
主要终点
Diagnosis

研究概览

简要总结

CureDuchenne link is a data hub comprised of integrated biospecimens, clinical data, and self- and/or caregiver-reported information from participants. Anyone over 4 weeks old who has been diagnosed with DMD or BMD or who is a carrier of DMD or BMD can join. Parents or legal guardians can sign up their child(ren).

详细描述

Individuals can participate through the CureDuchenne Link™ application (accessible via mobile device or web interface) and receive communications about research opportunities and community programs. Participation may be done using virtual methods, at a project site, and/or at community events nationwide.

All collected information will be stored in a secure, HIPAA-compliant data warehouse for approved researchers to use for studies relevant to DMD, BMD and other neuromuscular disorders. Combining health and outcomes data with biospecimens provides an impactful solution and novel resource for researchers, allowing for effective translational research.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
4 Weeks 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Any of the following are true:
  • •Currently has a confirmed diagnosis of DMD/BMD based on genetic testing, muscle biopsy, or clinical diagnosis.
  • •Currently has a confirmed diagnosis of carrier status for DMD/BMD based on genetic testing.
  • •Parent/guardian (for minor participants) or participant gives informed consent and/or assent as required by local regulations.
  • •Is age 4 weeks or older at the time of consent.

排除标准

  • •Is a foster child or ward of the state.
  • •Is a prisoner.

研究组 & 干预措施

Duchenne and Becker muscular dystrophy

Individuals with Duchenne muscular dystrophy and Becker muscular dystrophy

Carriers

Carriers of Duchenne muscular dystrophy and Becker muscular dystrophy

结局指标

主要结局

Diagnosis

时间窗: Upon study entry

There is no intervention in this project. Participants will provide documentation to support their diagnosis of Duchenne muscular dystrophy, Becker muscular dystrophy, or a carrier of these mutations

Genetic Mutation

时间窗: Upon study entry or when genetic testing results are available

Participants will be asked to provide genetic testing reports confirming their diagnosis, where available, which will be reviewed by a central genetic counselor.

次要结局

  • Cardiac Status(Upon study entry and every 6-12 months thereafter for up to ten (10) years)
  • Corticosteroid Status(Upon study entry and every 6-12 months thereafter for up to ten (10) years)
  • Functional Status(Upon study entry and every 6-12 months thereafter for up to ten (10) years)
  • North Star Ambulation Assessment (NSAA) Score(Upon study entry and every 6-12 months thereafter for up to ten (10) years)
  • 6 Minute Walk Test (6MWT) Score(Upon study entry and every 6-12 months thereafter for up to ten (10) years)
  • Respiratory Status(Upon study entry and every 6-12 months thereafter for up to ten (10) years)

研究者

发起方
CureDuchenne
申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

招募中
不适用
The Duchenne RegistryDuchenne Muscular DystrophyBecker Muscular DystrophyDystrophinopathyDystrophinopathy Symptomatic Female CarrierDystrophinopathy Female Carrier
NCT02069756The Duchenne Registry10,000
已完成
不适用
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsFacioscapulohumeral Muscular DystrophyIdiopathic Thrombocytopenic PurpuraSclerodermaSkin CancerChronic Inflammatory Demyelinating PolyneuropathyBeta ThalassemiaKidney CancerMyositisAsthmaAtopic Dermatitis EczemaHIV/AIDSPolycystic Kidney DiseasesPsoriasisRosaceaSickle Cell TraitTrisomy 21Celiac DiseaseLupus NephritisAnkylosing SpondylitisDepressionHereditary Hemorrhagic TelangiectasiaAll Diagnosed Health ConditionsADD/ADHDChronic Kidney DiseasesSjogren's SyndromeG6PD DeficiencyGeneral Anxiety DisorderHuman Papilloma VirusMyotonic DystrophyAlopecia AreataThrombotic Thrombocytopenic PurpuraHuntington's DiseaseDuchenne Muscular DystrophyChronic Obstructive Pulmonary DiseaseBreast CancerProstate CancerColorectal CancerLung CancerMultiple SclerosisMultiple MyelomaDiabetes MellitusOvarian CancerLymphomaPancreatic CancerEpilepsyCystic FibrosisLeukemiaMelanomaParkinson's DiseaseCervical CancerUlcerative ColitisInsomniaBipolar DisorderCrohn's DiseaseEndometriosisSystemic Lupus ErythematosusColon CancerHepatitis BPsoriatic ArthritisSpinal Muscular AtrophySickle Cell Anemia
NCT01931644Sanguine Biosciences17,667
已完成
不适用
DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic FloridaAmyotrophic Lateral Sclerosis (ALS)
NCT01699451Mayo Clinic33
招募中
不适用
Sudden Unexplained Death in Childhood (SUDC) RegistrySudden Unexplained Death SyndromeSudden Unexplained Death in Childhood
NCT03109197NYU Langone Health1,600
招募中
不适用
Lupus Landmark Study: A Prospective Registry and BiorepositoryLupus NephritisSystemic Lupus Erythematosus (SLE)Neuropsychiatric Systemic Lupus Erythematosus
NCT05934149Lupus Research Alliance3,500